{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:37:51Z","timestamp":1793410671803,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Z1A DA000389"],"award-info":[{"award-number":["Z1A DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41386-018-0231-5","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T23:12:12Z","timestamp":1538521932000},"page":"2615-2626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats"],"prefix":"10.1038","volume":"43","author":[{"given":"Jun-Tao","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-227X","authenticated-orcid":false,"given":"Chloe J.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hua","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot L.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-8104","authenticated-orcid":false,"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"231_CR1","unstructured":"World Health Organization. Management of substance abuse: Opiates. 2018 http:\/\/www.who.int\/substance_abuse\/facts\/opiates\/en\/ . Accessed 15 August 2018."},{"key":"231_CR2","unstructured":"Department of Health and Human Services. About the U.S. Opioid Epidemic. 2018. https:\/\/www.hhs.gov\/opioids\/about-the-epidemic\/ . Accessed 15 August 2018."},{"key":"231_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.","edition":"5th ed"},{"key":"231_CR4","unstructured":"American Society of Addiction Medicine. Opioid Addiction 2016 Facts & Figures. 2016. https:\/\/www.asam.org\/docs\/default-source\/advocacy\/opioid-addiction-disease-facts-figures.pdf . Accesssed 15 August 2018."},{"key":"231_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.dcn.2016.10.004","volume":"25","author":"CJ Jordan","year":"2017","unstructured":"Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cog Neurosci. 2017;25:29\u201344.","journal-title":"Dev Cog Neurosci"},{"key":"231_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fphar.2014.00116","volume":"5","author":"EH Chartoff","year":"2014","unstructured":"Chartoff EH, Connery HS. It\u2019s MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Front Pharmacol. 2014;5:116.","journal-title":"Front Pharmacol"},{"issue":"4","key":"231_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","volume":"38","author":"HL Fields","year":"2015","unstructured":"Fields HL, Margolis EB. Understanding opioid reward. Trends Neurosci. 2015;38(4):217\u201325.","journal-title":"Trends Neurosci"},{"issue":"2\u20133","key":"231_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF03033808","volume":"14","author":"RA Wise","year":"2008","unstructured":"Wise RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res. 2008;14(2\u20133):169\u201383.","journal-title":"Neurotox Res"},{"key":"231_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1749-6632.2010.05894.x","volume":"1216","author":"J Swendsen","year":"2011","unstructured":"Swendsen J, Le Moal M. Individual vulnerability to addiction. Ann NY Acad Sci. 2011;1216:73\u201385.","journal-title":"Ann NY Acad Sci"},{"issue":"8","key":"231_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10(8):561\u201372.","journal-title":"Nat Rev Neurosci"},{"issue":"1\u20133","key":"231_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2010.01.030","volume":"639","author":"K Moussawi","year":"2010","unstructured":"Moussawi K, Kalivas PW. Group II metabotropic glutamate receptors (mGlu2\/3) in drug addiction. Eur J Pharmacol. 2010;639(1\u20133):115\u201322.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"231_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12640-014-9502-z","volume":"27","author":"L Pomierny-Chamiolo","year":"2015","unstructured":"Pomierny-Chamiolo L, Miszkiel J, Frankowska M, Pomierny B, Niedzielska E, Smaga I, et al. Withdrawal from cocaine self-administration and yoked cocaine delivery dysregulates glutamatergic mGlu5 and NMDA receptors in the rat brain. Neurotox Res. 2015;27(3):246\u201358.","journal-title":"Neurotox Res"},{"issue":"3","key":"231_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biopsych.2017.08.018","volume":"84","author":"Daniele Caprioli","year":"2018","unstructured":"Caprioli D, Justinova Z, Venniro M, Shaham Y. Effect of novel allosteric modulators of metabotropic glutamate receptors on drug self-administration and relapse: a review of preclinical studies and their clinical implications. Biol Psychiatry. 2018;84:180\u201392.","journal-title":"Biological Psychiatry"},{"issue":"1","key":"231_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2004.02.015","volume":"47","author":"RG Greenslade","year":"2004","unstructured":"Greenslade RG, Mitchell SN. Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell. Neuropharmacology . 2004;47(1):1\u20138.","journal-title":"Neuropharmacology"},{"issue":"9","key":"231_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/00001756-200506210-00026","volume":"16","author":"JM Bossert","year":"2005","unstructured":"Bossert JM, Busch RF, Gray SM. The novel mGluR2\/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport . 2005;16(9):1013\u20136.","journal-title":"Neuroreport"},{"key":"231_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pbb.2015.06.004","volume":"135","author":"N Baharlouei","year":"2015","unstructured":"Baharlouei N, Sarihi A, Komaki A, Shahidi S, Haghparast A. Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II\/III in nucleus accumbens. Pharmacol Biochem Behav. 2015;135:192\u20138.","journal-title":"Pharmacol Biochem Behav"},{"key":"231_CR17","doi-asserted-by":"crossref","unstructured":"Baharlouei N, Sarihi A, Moradi M, Zarrabian S, Haghparast A. Microinjection of the mGluR2\/3 agonist, LY379268, into the nucleus accumbens attenuates extinction latencies and the reinstatement of morphine-induced conditioned place preference in rats. Behav Pharmacol. 2018.","DOI":"10.1097\/FBP.0000000000000375"},{"issue":"10","key":"231_CR18","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/sj.npp.1300977","volume":"31","author":"JM Bossert","year":"2006","unstructured":"Bossert JM, Gray SM, Lu L, Shaham Y. Activation of group II metabotropic glutamate receptors in the nucleus accumbens shell attenuates context-induced relapse to heroin seeking. Neuropsychopharmacology . 2006;31(10):2197\u2013209.","journal-title":"Neuropsychopharmacology"},{"issue":"47","key":"231_CR19","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1523\/JNEUROSCI.3207-04.2004","volume":"24","author":"JM Bossert","year":"2004","unstructured":"Bossert JM, Liu SY, Lu L, Shaham Y. A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci. 2004;24(47):10726\u201330.","journal-title":"J Neurosci"},{"key":"231_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.apha.2015.11.001","volume":"75","author":"S Chiechio","year":"2016","unstructured":"Chiechio S. Modulation of chronic pain by metabotropic glutamate receptors. Adv Pharmacol. 2016;75:63\u201389.","journal-title":"Adv Pharmacol"},{"key":"231_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-6","volume":"7","author":"M Zammataro","year":"2011","unstructured":"Zammataro M, Chiechio S, Montana MC, Traficante A, Copani A, Nicoletti F, et al. mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2\/mGlu3 receptor agonists. Mol Pain. 2011;7:6.","journal-title":"Mol Pain"},{"issue":"1","key":"231_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","volume":"139","author":"M Osikowicz","year":"2008","unstructured":"Osikowicz M, Mika J, Makuch W, Przewlocka B. Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain . 2008;139(1):117\u201326.","journal-title":"Pain"},{"issue":"6","key":"231_CR23","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/jnr.23025","volume":"90","author":"X Wu","year":"2012","unstructured":"Wu X, Shi M, Wei C, Yang M, Liu Y, Liu Z, et al. Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal. J Neurosci Res. 2012;90(6):1270\u201383.","journal-title":"J Neurosci Res"},{"issue":"5","key":"231_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.neuropharm.2003.11.013","volume":"46","author":"K Rasmussen","year":"2004","unstructured":"Rasmussen K, Hsu MA, Vandergriff J. The selective mGlu2\/3 receptor antagonist LY341495 exacerbates behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons. Neuropharmacology. 2004;46(5):620\u20138.","journal-title":"Neuropharmacology"},{"issue":"2","key":"231_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.celrep.2017.06.046","volume":"20","author":"HJ Yang","year":"2017","unstructured":"Yang HJ, Zhang HY, Bi GH, He Y, Gao JT, Xi ZX. Deletion of type 2 metabotropic glutamate receptor decreases sensitivity to cocaine reward in rats. Cell Rep. 2017;20(2):319\u201332.","journal-title":"Cell Rep"},{"issue":"9","key":"231_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/nn.2874","volume":"14","author":"ZX Xi","year":"2011","unstructured":"Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR, et al. Brain cannabinoid CB(2) receptors modulate cocaine\u2019s actions in mice. Nat Neurosci. 2011;14(9):1160\u20136.","journal-title":"Nat Neurosci"},{"issue":"1","key":"231_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","volume":"66","author":"NR Richardson","year":"1996","unstructured":"Richardson NR, Roberts DC. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods. 1996;66(1):1\u201311.","journal-title":"J Neurosci Methods"},{"key":"231_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuropharm.2018.08.016","volume":"141","author":"J Zhan","year":"2018","unstructured":"Zhan J, Jordan CJ, Bi GH, He XH, Gardner EL, Wang YL et al. Neuropharmacology genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice. Neuropharmacology. 2018;141:11\u201320.","journal-title":"Neuropharmacology"},{"issue":"3","key":"231_CR29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)31261-9","volume":"205","author":"VF Gellert","year":"1978","unstructured":"Gellert VF, Holtzman SG. Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther. 1978;205(3):536\u201346.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"231_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1037\/1064-1297.9.2.131","volume":"9","author":"WJ Lynch","year":"2001","unstructured":"Lynch WJ, Carroll ME. Regulation of drug intake. Exp Clin Psychopharmacology. 2001;9(2):131\u2013143.","journal-title":"Exp Clin Psychopharmacology"},{"key":"231_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","volume":"56","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine\u2019s role in drug abuse and addiction. Neuropharmacology. 2009;56:3\u20138.","journal-title":"Neuropharmacology"},{"issue":"43","key":"231_CR32","doi-asserted-by":"publisher","first-page":"17675","DOI":"10.1073\/pnas.1205297109","volume":"109","author":"R Song","year":"2012","unstructured":"Song R, Zhang HY, Li X, Bi GH, Gardner EL, Xi ZX. Increased vulnerability to cocaine in mice lacking dopamine D3 receptors. Proc Natl Acad Sci USA. 2012;109(43):17675\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\u20136","key":"231_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00008877-200209000-00008","volume":"13","author":"ND Volkow","year":"2002","unstructured":"Volkow ND, Fowler JS, Wang GJ. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol. 2002;13(5\u20136):355\u201366.","journal-title":"Behav Pharmacol"},{"issue":"42","key":"231_CR34","doi-asserted-by":"publisher","first-page":"16963","DOI":"10.1073\/pnas.1309839110","volume":"110","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Karlsson C, Liang T, Xiong W, Kimura M, Tapocik JD, et al. Loss of metabotropic glutamate receptor 2 escalates alcohol consumption. Proc Natl Acad Sci USA. 2013;110(42):16963\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"231_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-008-1432-0","volume":"204","author":"X Li","year":"2009","unstructured":"Li X, Hoffman AF, Peng XQ, Lupica CR, Gardner EL, Xi ZX. Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice. Psychopharmacology. 2009;204(1):1\u201311.","journal-title":"Psychopharmacology"},{"issue":"1","key":"231_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0006-8993(90)90431-A","volume":"514","author":"PV Piazza","year":"1990","unstructured":"Piazza PV, Deminiere JM, le Moal M, Simon H. Stress- and pharmacologically induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 1990;514(1):22\u20136.","journal-title":"Brain Res"},{"issue":"11","key":"231_CR37","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1523\/JNEUROSCI.20-11-04226.2000","volume":"20","author":"PV Piazza","year":"2000","unstructured":"Piazza PV, Deroche-Gamonent V, Rouge-Pont F, Le Moal M. Vertical shifts in self-administration dose\u2013response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci. 2000;20(11):4226\u201332.","journal-title":"J Neurosci"},{"issue":"9","key":"231_CR38","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/bies.201000042","volume":"32","author":"ND Volkow","year":"2010","unstructured":"Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain\u2019s control circuit. Bioessays. 2010;32(9):748\u201355.","journal-title":"Bioessays"},{"issue":"2","key":"231_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.npp.1300560","volume":"30","author":"SJ Ward","year":"2005","unstructured":"Ward SJ, Morgan D, Roberts DC. Comparison of the reinforcing effects of cocaine and cocaine\/heroin combinations under progressive ratio and choice schedules in rats. Neuropsychopharmacology. 2005;30(2):286\u201395.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"231_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<5::AID-CNE2>3.0.CO;2-6","volume":"390","author":"CM Testa","year":"1998","unstructured":"Testa CM, Friberg IK, Weiss SW, Standaert DG. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2\/3 in the rat basal ganglia. J Comp Neurol. 1998;390(1):5\u201319.","journal-title":"J Comp Neurol"},{"issue":"6","key":"231_CR41","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/cne.22194","volume":"517","author":"N Berube-Carriere","year":"2009","unstructured":"Berube-Carriere N, Riad M, Dal Bo G, Levesque D, Trudeau LE, Descarries L. The dual dopamine-glutamate phenotype of growing mesencephalic neurons regresses in mature rat brain. J Comp Neurol. 2009;517(6):873\u201391.","journal-title":"J Comp Neurol"},{"issue":"6","key":"231_CR42","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/ejn.12818","volume":"41","author":"T Yamaguchi","year":"2015","unstructured":"Yamaguchi T, Qi J, Wang HL, Zhang S, Morales M. Glutamatergic and dopaminergic neurons in the mouse ventral tegmental area. Eur J Neurosci. 2015;41(6):760\u201372.","journal-title":"Eur J Neurosci"},{"issue":"12","key":"231_CR43","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1523\/JNEUROSCI.5129-07.2008","volume":"28","author":"RT LaLumiere","year":"2008","unstructured":"LaLumiere RT, Kalivas PW. Glutamate release in the nucleus accumbens core is necessary for heroin seeking. J Neurosci. 2008;28(12):3170\u20137.","journal-title":"J Neurosci"},{"issue":"16","key":"231_CR44","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1523\/JNEUROSCI.4564-13.2014","volume":"34","author":"HW Shen","year":"2014","unstructured":"Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW. Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci. 2014;34(16):5649\u201357.","journal-title":"J Neurosci"},{"key":"231_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2008.12.003","volume":"1","author":"LA Knackstedt","year":"2009","unstructured":"Knackstedt LA, Kalivas PW. Glutamate and reinstatement. Curr Opin Pharmacol. 2009;1:59\u201364.","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"231_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1046\/j.1460-9568.1999.00488.x","volume":"11","author":"M Diana","year":"1999","unstructured":"Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci. 1999;11(3):1037\u201341.","journal-title":"Eur J Neurosci"},{"issue":"5","key":"231_CR47","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s00429-013-0599-2","volume":"219","author":"L Sun","year":"2014","unstructured":"Sun L, Hu L, Li Y, Cui C. Mesoaccumbens dopamine signaling alteration underlies behavioral transition from tolerance to sensitization to morphine rewarding properties during morphine withdrawal. Brain Struct Funct. 2014;219(5):1755\u201371.","journal-title":"Brain Struct Funct"},{"issue":"5","key":"231_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nn.4281","volume":"19","author":"J Qi","year":"2016","unstructured":"Qi J, Zhang S, Wang HL, Barker DJ, Miranda-Barrientos J, Morales M. VTA glutamatergic inputs to nucleus accumbens drive aversion by acting on GABAergic interneurons. Nat Neurosci. 2016;19(5):725\u201333.","journal-title":"Nat Neurosci"},{"issue":"3","key":"231_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00213-009-1482-y","volume":"204","author":"PJ Meyer","year":"2009","unstructured":"Meyer PJ, Morgan MM, Kozell LB, Ingram SL. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology. 2009;204(3):531\u201340.","journal-title":"Psychopharmacology"},{"issue":"2","key":"231_CR50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0006-8993(99)02396-3","volume":"855","author":"JE Magnusson","year":"2000","unstructured":"Magnusson JE, Fisher K. The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum. Brain Res. 2000;855(2):260\u20136.","journal-title":"Brain Res"},{"issue":"1","key":"231_CR51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3565(24)37364-1","volume":"285","author":"N Altier","year":"1998","unstructured":"Altier N, Stewart J. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther. 1998;285(1):208\u201315.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"231_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pharmthera.2007.10.003","volume":"117","author":"T Koch","year":"2008","unstructured":"Koch T, Hollt V. Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther. 2008;117(2):199\u2013206.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"231_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al. Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev. 2013;65(1):223\u201354.","journal-title":"Pharmacol Rev"},{"key":"231_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.08.009","volume":"59","author":"G Yu","year":"2014","unstructured":"Yu G, Zhang FQ, Tang SE, Lai MJ, Su RB, Gong ZH. Continuous infusion versus intermittent bolus dosing of morphine: a comparison of analgesia, tolerance, and subsequent voluntary morphine intake. J Psychiatr Res. 2014;59:161\u20136.","journal-title":"J Psychiatr Res"},{"issue":"40","key":"231_CR55","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1523\/JNEUROSCI.0603-16.2016","volume":"36","author":"Xiao-Fei Wang","year":"2016","unstructured":"Wang XF, Barbier E, Chiu YT, He Y, Zhan J, Bi GH, Zhang HY, Feng B, Liu-Chen LY, Wang JB, Xi ZX. T394A mutation at the \u03bc opioid receptor blocks opioid tolerance and increases vulnerability to heroin self-administration in mice. J Neurosci. 2016;36:10392\u2013403.","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"231_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0091-3057(97)00550-9","volume":"60","author":"MJ Sepulveda","year":"1998","unstructured":"Sepulveda MJ, Hernandez L, Rada P, Tucci S, Contreras E. Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study. Pharmacol Biochem Behav. 1998;60(1):255\u201362.","journal-title":"Pharmacol Biochem Behav"},{"issue":"2\u20133","key":"231_CR57","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejphar.2003.10.037","volume":"483","author":"J Sepulveda","year":"2004","unstructured":"Sepulveda J, Oliva P, Contreras E. Neurochemical changes of the extracellular concentrations of glutamate and aspartate in the nucleus accumbens of rats after chronic administration of morphine. Eur J Pharmacol. 2004;483(2\u20133):249\u201358.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"231_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jjp.76.1","volume":"76","author":"H Zhu","year":"1998","unstructured":"Zhu H, Rockhold RW, Ho IK. The role of glutamate in physical dependence on opioids. Jpn J Pharmacol. 1998;76(1):1\u201314.","journal-title":"Jpn J Pharmacol"},{"issue":"11","key":"231_CR59","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1046\/j.1460-9568.2002.02273.x","volume":"16","author":"D Robbe","year":"2002","unstructured":"Robbe D, Bockaert J, Manzoni OJ. Metabotropic glutamate receptor 2\/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice. Eur J Neurosci. 2002;16(11):2231\u20135.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"231_CR60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","volume":"19","author":"R Spanagel","year":"2017","unstructured":"Spanagel R. Animal models of addiction. Dialogues Clin Neurosci. 2017;19(3):247\u201358.","journal-title":"Dialogues Clin Neurosci"},{"issue":"20","key":"231_CR61","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1021\/jm300912k","volume":"55","author":"JI Andres","year":"2012","unstructured":"Andres JI, Alcazar J, Cid JM, De Angelis M, Iturrino L, Langlois X, et al. Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging. J Med Chem. 2012;55(20):8685\u201399.","journal-title":"J Med Chem"},{"key":"231_CR62","first-page":"213","volume":"57","author":"T Lohith","year":"2016","unstructured":"Lohith T, McQuade P, Salinas C, Anderson M, Reynders T, Bautmans A et al. First-in-human PET imaging of mGluR2 receptors. J Nucl Med. 2016;57:213.","journal-title":"J Nucl Med"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0231-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0231-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0231-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:47:14Z","timestamp":1761097634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0231-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":62,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0231-5","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}